Medicine and Dentistry
Intensive Care Unit
88%
Patient
85%
COVID-19
65%
Thromboembolism
43%
Mortality
27%
Follow up
25%
Age
22%
Artificial Respiration
20%
Organ
15%
Chronic Lung Disease
15%
Fatigue
14%
Thrombosis
12%
Thromboprophylaxis
12%
Bleeding
12%
Observational Study
12%
Proportional Hazards Model
11%
Gender
10%
Male
10%
Hospital
10%
Morbidity
10%
Intensive Care
9%
Renal Replacement Therapy
7%
Malignant Neoplasm
7%
Functional Status
7%
Activities of Daily Living
7%
Enalapril Maleate
7%
Assessment
7%
Hematologic Malignancy
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Hazard Ratio
6%
Major Bleeding
6%
Coagulation
6%
Heparin
6%
Association
6%
Low Platelet Count
6%
D-Dimer
6%
Analysis
6%
Man
5%
Regression Analysis
5%
Extracorporeal Membrane Oxygenation
5%
Hypertension
5%
Long Term Survival
5%
Hypertensive Factor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Thromboembolism
43%
Mortality
27%
Death
15%
Comorbidity
15%
Chronic Lung Disease
15%
Fatigue
14%
Thrombosis
12%
Bleeding
12%
Frailty
10%
Morbidity
10%
Malignant Neoplasm
7%
Functional Status
7%
Enalapril Maleate
7%
Hematologic Malignancy
6%
Heparin
6%
D Dimer
6%
Observational Study
5%
Long Term Survival
5%
Diabetes Mellitus
5%
Hypertension
5%
Hypertensive Factor
5%
Nursing and Health Professions
Patient
100%
Intensive Care Unit
28%
Confidence Interval
14%
Fatigue
14%
Frailty
10%
Follow up
10%
Mortality
9%
Length of Stay
8%
Quality of Life
7%
Functional Status
7%
Enalapril Maleate
7%
Inpatient
5%
Death
5%
Comorbidity
5%
